Tag Archives: brain

Brain health supplements offer mostly hype, false hope

Leave a reply
Liz Seegert

About Liz Seegert

Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News, the Connecticut Health I-Team and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.

brainHealthSupplements

Photo: Kenny Stoltz via Flickr

I don’t know about you, but every time I see a commercial for one particular supplement marketed to improve brain health, I cringe. The ad is misleading and can lead people to think that consuming essentially an unregulated blend of herbs and spices can help stave off cognitive decline or even prevent Alzheimer’s. If only it were true.

The ads are so misleading that the Federal Trade Commission and state of New York actually took the manufacturer to court in 2017 to get the company to stop airing them. (A judge later dismissed charges against the company’s former president, but let the rest of the suit go forward). Continue reading →

Poor sleep quality linked to increased Alzheimer’s risk in Hispanics

1 Reply
Liz Seegert

About Liz Seegert

Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News, the Connecticut Health I-Team and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.

Sleep disturbances among Hispanics may increase their risk of cognitive impairment and Alzheimer's disease, according to a new study.

Photo: Alex Proimos via Flickr

Sleep disturbances among Hispanics may increase their risk of cognitive impairment and Alzheimer’s disease, according to a new study. Researchers found that insomnia and prolonged sleep duration appear to be linked to a decline in neurocognitive functioning that can precede the onset of Alzheimer’s disease or other dementias.

This finding is particularly important because Hispanics have a significantly higher risk of Alzheimer’s disease compared with non-Hispanic whites. Onset also occurs sooner, according to prior research from Duke University. Continue reading →

Researchers identify new Alzheimer’s-like condition

2 Replies
Liz Seegert

About Liz Seegert

Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News, the Connecticut Health I-Team and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.

Image: Brain by Injurymap.

A recently recognized dementia that mimics many of the hallmarks of Alzheimer’s disease, but actually is an entirely different form of brain deterioration, has been documented in a new research paper.

Limbic-predominant age-related TDP-43 encephalopathy (also known as LATE) primarily affects adults 80 years and older and “has been associated with substantial cognitive impairment that mimicked Alzheimer’s disease,” said researchers of the paper, which appeared in the June edition of Brain: A Journal of Neurology. Continue reading →

Survey highlights desire for involvement in Alzheimer’s trials, early detection

Leave a reply
Liz Seegert

About Liz Seegert

Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News, the Connecticut Health I-Team and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.

Would you want to know if you were at risk of Alzheimer’s disease, although it’s incurable and treatment options are limited?

Most people said yes” according to a recent survey from the Alliance for Aging Research conducted by Avalere Health. The vast majority of those surveyed also said that early detection is important to them and that they are willing to participate in clinical trials. Continue reading →

New resources can help you better report on Parkinson’s disease

3 Replies
Liz Seegert

About Liz Seegert

Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News, the Connecticut Health I-Team and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.

Photo: Alan Kotok via FlickrActor Alan Alda is among an estimated 10 million people worldwide living with Parkinson’s disease.

Parkinson’s disease (PD) can be a devastating diagnosis, but most people can lead full, active lives for many years thanks to medications that can control common symptoms, as well as surgical options, speech and physical therapy and lifestyle changes.

Actor Alan Alda, 82, recently revealed he had the condition during an appearance on CBS This Morning. He’s one of about 60,000 people in the U.S. diagnosed with PD each year. More than 10 million people worldwide are living with this progressive neurological disorder, according to the Parkinson’s Disease Foundation. There is no cure. Continue reading →

Increased optimism about new Alzheimer’s drugs, tests

Leave a reply
Liz Seegert

About Liz Seegert

Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News, the Connecticut Health I-Team and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.

Photo: AJ Cann via Flickr

You may have recently heard about the multimillion-dollar donation that Bill Gates and Leonard Lauder made to support research into biomarkers for early detection of Alzheimer’s disease and related dementias.

The Diagnostics Accelerator initiative is part of the Alzheimer’s Drug Discovery Foundation’s (ADDF) effort to speed diagnosis and develop drugs that can prevent, treat, and cure the disease. Lauder was an ADDF co-founder. Continue reading →